Literature DB >> 21158375

Surgery for full-thickness macular hole in patients with idiopathic macular telangiectasia type 2.

Ninel Gregori1, Harry W Flynn.   

Abstract

The authors report surgical outcomes of full-thickness macular hole repair in two patients with idiopathic macular telangiectasia in a non-comparative case series. Both patients underwent pars plana vitrectomy with indocyanine green-assisted internal limiting membrane peeling and injection of 16% C(3)F(8) gas. Patients were imaged with optical coherence tomography (OCT) before and after surgery. The first patient demonstrated macular hole closure on examination and OCT with visual improvement from 20/50 preoperatively to 20/30 after macular hole surgery and subsequent cataract surgery. The second patient's hole closed per OCT immediately after surgery but reopened 4 months later, and visual acuity remained 20/70. Macular hole surgery may be an effective treatment in patients with idiopathic macular telangiectasia and full-thickness macular holes and should be further investigated. Copyright 2010, SLACK Incorporated.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 21158375     DOI: 10.3928/15428877-20100726-10

Source DB:  PubMed          Journal:  Ophthalmic Surg Lasers Imaging        ISSN: 1542-8877


  9 in total

1.  "Doctor, why is my macular hole still open?".

Authors:  Mei Hong Tan; Fred Kuanfu Chen
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2013-10-18       Impact factor: 3.117

2.  Spontaneous closure of full-thickness macular hole in type 2 idiopathic macular telangiectasia.

Authors:  Dhananjay Shukla; Ramesh Venkatesh
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2011-09-22       Impact factor: 3.117

3.  Two years outcomes of treating full-thickness macula hole associated with idiopathic macular telangiectasia type 2 by internal limiting membrane inverted flap technique: Case reports.

Authors:  Shungo Nishiyama; Takeshi Iwase
Journal:  Medicine (Baltimore)       Date:  2021-09-10       Impact factor: 1.817

Review 4.  Macular telangiectasia type 2.

Authors:  Peter Charbel Issa; Mark C Gillies; Emily Y Chew; Alan C Bird; Tjebo F C Heeren; Tunde Peto; Frank G Holz; Hendrik P N Scholl
Journal:  Prog Retin Eye Res       Date:  2012-12-03       Impact factor: 21.198

5.  Comparison of observation, intravitreal bevacizumab, or pars plana vitrectomy for non-proliferative type 2 idiopathic macular telangiectasia.

Authors:  Eric J Sigler; John C Randolph; Jorge I Calzada; Steve Charles
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2012-09-06       Impact factor: 3.117

Review 6.  Multimodality imaging in macular telangiectasia 2: A clue to its pathogenesis.

Authors:  Lihteh Wu
Journal:  Indian J Ophthalmol       Date:  2015-05       Impact factor: 1.848

7.  Lamellar hole-associated epiretinal proliferation presenting with perifoveal exudative vascular anomalous complex.

Authors:  Jakob Siedlecki; Efstathios Vounotrypidis; Denise Vogt; Armin Wolf; Siegfried G Priglinger; Ricarda G Schumann
Journal:  Am J Ophthalmol Case Rep       Date:  2019-04-04

8.  Surgical Outcomes in Macular Telangiectasia Type 2-Related Macular Holes: A Report on Four Patients.

Authors:  Kinza T Ahmad; Joseph Chacko; Ahmed B Sallam; David B Warner; Sami H Uwaydat
Journal:  Case Rep Ophthalmol Med       Date:  2020-12-07

Review 9.  When is macular edema not macular edema? An update on macular telangiectasia type 2.

Authors:  Lihteh Wu
Journal:  Taiwan J Ophthalmol       Date:  2015-11-14
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.